Please check your internet connection and try again.
# Arsil-DX
## Overview
Arsil-DX (typically a combination product containing **Dextromethorphan HBr** and often an expectorant like **Guaifenesin**) is an over-the-counter antitussive and protussive agent. Dextromethorphan acts centrally on the cough center in the medulla to elevate the cough threshold.
## Primary Indications
Symptomatic relief of non-productive cough associated with the common cold, bronchitis, or inhaled irritants.
## Adult Dosing
* **Dextromethorphan:** 10–20 mg orally every 4 hours or 30 mg every 6–8 hours as needed.
* **Maximum Dose:** 120 mg per 24 hours.
## Pediatric Dosing
* **Children 6 to 12 years:** 5–10 mg orally every 4 hours or 15 mg every 6–8 hours.
* **Maximum Dose:** 60 mg per 24 hours.
* *Note:* Strictly avoid in children under 4 years of age due to lack of efficacy and safety concerns; clinical guidelines discourage use in children under 6 years unless directed by a pediatrician.
## Dose Adjustments
* **Hepatic Impairment:** Reduce dosage or increase dosing intervals in patients with significant hepatic impairment, as dextromethorphan is extensively metabolized by CYP2D6.
* **Renal Impairment:** No specific guidelines; use with caution.
## Contraindications
* Hypersensitivity to any component.
* Concurrent use or within 14 days of **MAO inhibitors** (risk of serotonin syndrome).
## Adverse Effects
* **Common:** Dizziness, drowsiness, nausea, vomiting, stomach pain.
* **Serious (Rare/Overdose):** Serotonin syndrome (agitation, tachycardia, hyperreflexia), hallucinations, confusion, and respiratory depression.
## Key Drug Interactions
* **MAOIs:** Fatal hyperpyretic crises may occur.
* **SSRIs/SNRIs:** Increased risk of serotonin syndrome.
* **CNS Depressants (Alcohol, Benzos):** Potentiation of sedative effects.
* **CYP2D6 Inhibitors (e.g., Fluoxetine, Quinidine):** May significantly increase plasma concentrations of dextromethorphan.
## Monitoring
* Monitor for symptom resolution and evidence of abuse/misuse.
* Monitor for signs of CNS toxicity if combined with other serotonergic agents.
## Clinical Pearls
* **Efficacy:** Evidence for over-the-counter cough suppressants is often considered weak in clinical trials; non-pharmacologic interventions (hydration, honey) are preferred for minor coughs.
* **Abuse Potential:** Due to its dissociative properties at high doses, dextromethorphan has a high risk for recreational misuse ("robotripping").
* **Product Clarity:** Always verify the active ingredients; many "DX" labeled products contain combination ingredients (acetaminophen, antihistamines) that require separate dosing safety considerations.
***
*Disclaimer: This information is for educational purposes only. Always verify specific dosing, safety information, and local clinical protocols using the official package insert or a reliable clinical database (e.g., Lexicomp, Micromedex) before prescribing or administering medication.*
